Zobrazeno 1 - 10
of 80
pro vyhledávání: '"M B Agarwal"'
Autor:
M B Agarwal
Publikováno v:
Asian Journal of Transfusion Science, Vol 10, Iss 3, Pp 1-7 (2016)
Externí odkaz:
https://doaj.org/article/f0bcc95a80124b9ebc248189b6ab56ec
Autor:
M B, Agarwal, Swati, Pai
Publikováno v:
The Journal of the Association of Physicians of India. 65(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a7b2587665dcc2e9cfe567fc5490662
https://pubmed.ncbi.nlm.nih.gov/31556265
https://pubmed.ncbi.nlm.nih.gov/31556265
Autor:
A. Chiddarwar, Malay B. Mukherjee, Prashant Warang, Prabhakar Kedar, M B Agarwal, Rati Devendra, Vinod Gupta
Publikováno v:
Indian journal of hematologyblood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 35(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70e2ca022548c94c0d3e63e4ed1487e
https://pubmed.ncbi.nlm.nih.gov/30988594
https://pubmed.ncbi.nlm.nih.gov/30988594
Autor:
Jamshed J. Dalal, Anil Kumar Tripathi, Manoranjan Mahapatra, Anand Deshpande, Abhay Bhave, M B Agarwal, Subhash Verma, Amit Vora, S. Bichu, A. B. Shah
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 28:129-143
With the evaluation and approval of newer oral anticoagulants such as the factor IIa inhibitor, dabigatran etexilate and the factor Xa inhibitors, rivaroxaban and apixaban, strategies for stroke prevention in atrial fibrillation need a thorough re-ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8dd49a4b02029962cdb44bdce1f9072
https://doi.org/10.1007/s12288-012-0167-6
https://doi.org/10.1007/s12288-012-0167-6
Autor:
M B Agarwal
Multiple myeloma (MM) is a heterogeneous disease with varied outcome. The novel agents including two major classes of drugs; the immunomodulatory drugs and the proteasome inhibitors with unprecedented response rates, have replaced conventional chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f415ad45856ccfff05752b5fae6c7a
https://europepmc.org/articles/PMC4733675/
https://europepmc.org/articles/PMC4733675/
Autor:
M B, Agarwal
Publikováno v:
The Journal of the Association of Physicians of India. 62(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f9122d2d8c0ff3579bec7316697b21e
https://pubmed.ncbi.nlm.nih.gov/25906514
https://pubmed.ncbi.nlm.nih.gov/25906514
To confirm the safety and efficacy of an indigenous equine antithymocyte globulin (eATG) along with cyclosporine in Indian subjects with acquired aplastic anaemia. Subjects >2 years old with acquired aplastic anaemia were enrolled at six hospitals be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567e4bc760e392249932a745060de01f
https://europepmc.org/articles/PMC4375142/
https://europepmc.org/articles/PMC4375142/
Autor:
M. B. Agarwal
Publikováno v:
The Indian Journal of Pediatrics. 60:509-516
Due to the high cost and inconvenient mode of administration of desferrioxoxamine (DFO), search has been on to find an orally effective, non-toxic and cheaper iron chelator for quite some time2 During the last thirteen years, deferiprone or 1,2Dimeth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198ee5864f38288b1c132ca663c3d302
https://doi.org/10.1007/bf02751427
https://doi.org/10.1007/bf02751427
Publikováno v:
The Journal of the Association of Physicians of India. 54
Invasive fungal infections are difficult to eradicate especially in immuno-compromised host. Amphotericin B and voriconazole have been the mainstay of treatment but both have significant toxicity. Caspofungin belongs to a new class of antifungal agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85d69463de6674e7a1b16a874243ceb0
https://pubmed.ncbi.nlm.nih.gov/17334012
https://pubmed.ncbi.nlm.nih.gov/17334012
Autor:
M B, Agarwal
Publikováno v:
The Journal of the Association of Physicians of India. 54
ICL670(deferasirox) is a tridentate oral iron chelator that has shown high efficacy and theraputic safety in preclinical and currently ongoing phase III clinical evaluation. The drug has been just approved by US FDA for use in iron-loading anaemias.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9ce7e5baaab03fb847ae143ea69fbb0
https://pubmed.ncbi.nlm.nih.gov/16800349
https://pubmed.ncbi.nlm.nih.gov/16800349